Gene: GMDS
Official Full Name: GDP-mannose 4,6-dehydrataseprovided by HGNC
Gene Summary: GDP-mannose 4,6-dehydratase (GMD; EC 4.2.1.47) catalyzes the conversion of GDP-mannose to GDP-4-keto-6-deoxymannose, the first step in the synthesis of GDP-fucose from GDP-mannose, using NADP+ as a cofactor. The second and third steps of the pathway are catalyzed by a single enzyme, GDP-keto-6-deoxymannose 3,5-epimerase, 4-reductase, designated FX in humans (MIM 137020).[supplied by OMIM, Aug 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37617 | GMDS Knockout cell line (HeLa) | Human | GMDS | 1:3~1:6 | Negative | Online Inquiry |
KO37618 | GMDS Knockout cell line (HCT 116) | Human | GMDS | 1:2~1:4 | Negative | Online Inquiry |
KO37619 | GMDS Knockout cell line (HEK293) | Human | GMDS | 1:3~1:6 | Negative | Online Inquiry |
KO37620 | GMDS Knockout cell line (A549) | Human | GMDS | 1:3~1:4 | Negative | Online Inquiry |
GMDS Gene Knockout Cell Lines are sophisticated tools designed for researchers to explore the genetic underpinnings of cellular function by specifically disrupting the GMDS (GDP-mannose 4,6-dehydratase) gene. The GMDS gene plays a critical role in polysaccharide synthesis and glycosylation pathways crucial for cell signaling and immune responses. By employing CRISPR-Cas9 technology, these knockout cell lines enable precise and targeted gene editing, allowing researchers to investigate the physiological and pathological implications of GMDS deficiency.
The cell lines operate through a well-established mechanism where the CRISPR-Cas9 system introduces double-strand breaks in the DNA at the specific GMDS locus, which, when repaired by non-homologous end joining, leads to gene disruption. This selective knockout assists in elucidating the gene's functional roles in various biological processes including cell proliferation, differentiation, and stress responses, thereby facilitating invaluable insights into its contributions to diseases, including cancer and metabolic disorders.
The scientific importance of GMDS Gene Knockout Cell Lines cannot be overstated, as they serve as a platform for the identification of new therapeutic targets and the validation of drug candidates. Their ability to recapitulate in vivo-like conditions makes them suitable for high-throughput screening and mechanistic studies in both academic and clinical settings.
What sets these cell lines apart from conventional models is their precise editing capabilities, high efficiency, and reliability, coupled with a comprehensive suite of accompanying reagents for downstream applications such as Western blotting, qPCR, and functional assays. This specificity dramatically reduces the chances of off-target effects and provides robust data essential for scientific discovery.
For researchers and clinicians looking to deepen their understanding of GMDS-related pathways, these knockout cell lines offer a versatile and powerful approach. By utilizing GMDS Gene Knockout Cell Lines, users can advance their research with confidence, knowing they have access to a model that minimizes variability and enhances reproducibility.
Our company prides itself on its extensive expertise in genetic engineering and biological product development, providing researchers with high-quality tools tailored for innovative exploration and superior results. With our products, you are not just buying a tool; you are investing in your research’s success and advancement.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.